These findings collectively suggest that elevated ALT reflects both hepatic injury and altered pharmacodynamics, emphasizing the need for careful monitoring and management of HCC patients with impaired liver function, particularly since interventional therapies can further exacerbate hepatic stress (39, 40). Here, GPT is linked to hepatocellular carcinoma.